0 CHECKOUT

Global Sexual Health Partnering 2010-2016: Deal trends, players and financials

  • ID: 2229066
  • July 2016
  • Region: Global
  • 250 pages
  • CurrentPartnering
1 of 4

Global Sexual Health Partnering 2010 to 2016 provides the full collection of Sexual Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Sexual Health partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Sexual Health partnering agreement structure
Sexual Health partnering contract documents
Top Sexual Health deals by value
Most active Sexual Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sexual Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sexual Health deals.

The report presents financial deal terms values for Sexual Health deals, where available listing by overall headline values, upfront payments, milestones READ MORE >

Note: Product cover images may vary from those shown
2 of 4

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sexual Health dealmaking

2.1. Introduction
2.2. Sexual Health partnering over the years
2.3. Sexual Health partnering by deal type
2.4. Sexual Health partnering by industry sector
2.5. Sexual Health partnering by stage of development
2.6. Sexual Health partnering by technology type
2.7. Sexual Health partnering by therapeutic indication

Chapter 3 -Financial deal terms for Sexual Health partnering

3.1. Introduction
3.2. Disclosed financials terms for Sexual Health partnering
3.3. Sexual Health partnering headline values
3.4. Sexual Health deal upfront payments
3.5. Sexual Health deal milestone payments
3.6. Sexual Health royalty rates

Chapter 4 - Leading Sexual Health deals and dealmakers

4.1. Introduction
4.2. Most active in Sexual Health partnering
4.3. List of most active dealmakers in Sexual Health
4.4. Top Sexual Health deals by value

Chapter 5 - Sexual Health contract document directory

5.1. Introduction
5.2. Sexual Health partnering deals where contract document available

Chapter 6 - Sexual Health dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Sexual Health therapeutic target

Appendices

Appendix 1 - Directory of Sexual Health deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Sexual Health deals by deal type 2010 to 2016
Appendix 3 - Directory of Sexual Health deals by stage of development 2010 to 2016
Appendix 4 - Directory of Sexual Health deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Sexual Health partnering since 2010
Figure 2: Sexual Health partnering by deal type since 2010
Figure 3: Sexual Health partnering by industry sector since 2010
Figure 4: Sexual Health partnering by stage of development since 2010
Figure 5: Sexual Health partnering by technology type since 2010
Figure 6: Sexual Health partnering by indication since 2010
Figure 7: Sexual Health deals with a headline value
Figure 8: Sexual Health deals with upfront payment values
Figure 9: Sexual Health deals with milestone payment
Figure 10: Sexual Health deals with royalty rates
Figure 11: Active Sexual Health dealmaking activity- 2010 to 2016
Figure 12: Top Sexual Health deals by value since 2010

Note: Product cover images may vary from those shown
3 of 4

Global Sexual Health Partnering 2010 to 2016 provides the reader with the following key benefits:

In-depth understanding of Sexual Health deal trends since 2010
Access Sexual Health deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between Sexual Health partner companies
Comprehensive access to over 750 links to actual Sexual Health deals entered into by the world’s biopharma companies
Indepth review of Sexual Health deals entered into by the top 25 most active dealmakers
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner Sexual Health opportunities
Uncover companies actively partnering Sexual Health opportunities

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Inc.
  • Merck & Co., Inc.